Staff Surgeon
Disclosure information not submitted.
eP807 - Functional Outcomes after Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results from the Phase II North American Multicenter Trial
Monday, June 3, 202410:54 AM – 10:59 AM ET, USA